18F-GE180, a radioligand for the TSPO protein: not ready for clinical trials in multiple sclerosis
Eur J Nucl Med Mol Imaging
.
2020 Sep;47(10):2242-2243.
doi: 10.1007/s00259-020-04844-5.
Epub 2020 May 8.
Authors
Richard Nicholas
1
2
,
David Brooks
3
4
,
David Owen
3
Affiliations
1
Division of Brain Sciences, Faculty of Medicine, Imperial College London, Hammersmith Hospital Campus, London, UK. r.nicholas@imperial.ac.uk.
2
Imperial College London, Charing Cross Hospital, Room 10L18, Fulham Palace Road, London, W6 8RF, UK. r.nicholas@imperial.ac.uk.
3
Division of Brain Sciences, Faculty of Medicine, Imperial College London, Hammersmith Hospital Campus, London, UK.
4
Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark.
PMID:
32383091
DOI:
10.1007/s00259-020-04844-5
No abstract available
Publication types
Letter
Comment
MeSH terms
Fluorine Radioisotopes
Humans
Indoles
Multiple Sclerosis* / drug therapy
Receptors, GABA
Substances
18F-GE180
Fluorine Radioisotopes
Indoles
Receptors, GABA
TSPO protein, human
Grants and funding
MR/N008219/1/MRC_/Medical Research Council/United Kingdom
MR/T031891/1/MRC_/Medical Research Council/United Kingdom